Insider · CIK 0001693564
Lori Lyons-Williams
Files at RAPT (RAPT Therapeutics, Inc.), CTNM (Contineum Therapeutics, Inc.). First filing -, latest -.
In brief
Lori Lyons-Williams files SEC Form 4 as director at RAPT (RAPT Therapeutics, Inc.), and also at CTNM (Contineum Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lori Lyons-Williams has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 26, 2026 |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | UTender of shares Common Stock | -4,956 | - | - | 0 | Mar 5, 2026 |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | DDisposition to issuer Director Stock Option (right to buy)derivative | -2,813 | - | - | 0 | Mar 5, 2026 |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | DDisposition to issuer Director Stock Option (right to buy)derivative | -1,063 | - | - | 0 | Mar 5, 2026 |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | DDisposition to issuer Director Stock Option (right to buy)derivative | -1,618 | - | - | 0 | Mar 5, 2026 |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | DDisposition to issuer Director Stock Option (right to buy)derivative | -4,561 | - | - | 0 | Mar 5, 2026 |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | DDisposition to issuer Director Stock Option (right to buy)derivative | -32,229 | - | - | 0 | Mar 5, 2026 |
| Jan 30, 2026 | RAPT RAPT Therapeutics, Inc. | AGrant or award Common Stock | +4,956 | $0.00 | $0 | 4,956 | Feb 2, 2026 |
| Jun 26, 2025 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,750 | $0.00 | $0 | 14,750 | Jun 26, 2025 |
| May 29, 2025 | RAPT RAPT Therapeutics, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +257,832 | $0.00 | $0 | 257,832 | Jun 2, 2025 |
Questions about Lori Lyons-Williams
Answered from the filings on this page, as of the latest one.
Is Lori Lyons-Williams buying or selling?
Lori Lyons-Williams has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lori Lyons-Williams's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lori Lyons-Williams has 0.
Where does Lori Lyons-Williams file Form 4?
Lori Lyons-Williams has filed Form 4 at RAPT (RAPT Therapeutics, Inc.); CTNM (Contineum Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.